MLchartDataset catalogue

XR9576

Term · Oncology and biomedicine · MLC-T-ONC-009422

A substance that is being studied in the treatment of cancer. It may help tumor cells respond again to drugs they have become resistant (unable to respond) to. XR9576 is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called tariquidar.

Table 1. Record
IdentifierMLC-T-ONC-009422
FieldOncology and biomedicine
Expansionstariquidar
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-009422",
  "term": "XR9576",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of cancer. It may help tumor cells respond again to drugs they have become resistant (unable to respond) to. XR9576 is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist. Also called tariquidar.",
  "expansions": [
    "tariquidar"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/xr9576/"
}

Record 17,518 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.